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ABSTRACT
There is a growing need for fast and accurate methods for testing developmental neurotoxicity across
several chemical exposure sources. Current approaches, such as in vivo animal studies, and assays
of animal and human primary cell cultures, suffer from challenges related to time, cost, and appli-
cability to human physiology. We previously demonstrated success employing machine learning
to predict developmental neurotoxicity using gene expression data collected from human 3D tissue
models exposed to various compounds. The 3D model is biologically similar to developing neural
structures, but its complexity necessitates extensive expertise and effort to employ. By instead fo-
cusing solely on constructing an assay of developmental neurotoxicity, we propose that a simpler
2D tissue model may prove sufficient. We thus compare the accuracy of predictive models trained
on data from a 2D tissue model with those trained on data from a 3D tissue model, and find the 2D
model to be substantially more accurate. Furthermore, we find the 2D model to be more robust under
stringent gene set selection, whereas the 3D model suffers substantial accuracy degradation. While
both approaches have advantages and disadvantages, we propose that our described 2D approach
could be a valuable tool for decision makers when prioritizing neurotoxicity screening.
Keywords machine learning, neurotoxicity, tissue model, gene expression
Introduction
The Toxic Substances Control Act (TSCA) lists 84,000 chemicals, almost all of which have not been tested for devel-
opmental neurotoxicity [1]. The developing human brain is especially sensitive to toxic exposures [2], and estimated
costs of early developmental neurotoxicity exposure are enormous [3, 4]. Fast, inexpensive, and accurate methods for
testing developmental neurotoxicity are thus urgently needed.
Current approaches involve in vivo animal studies, and assays of animal and human primary cell and tissue cultures.
These approaches suffer from challenges such as time, cost, availability of primary cells and tissues, and poor appli-
cability to human physiology [5, 6, 7]. The result of these difficulties can be observed in part by a decrease in drug
approval rates despite increases in research and development spending [8]. Human pluripotent stem cells can help
address these challenges by providing a scalable source of applicable human cells at relatively low cost.
In 2012, the National Institutes of Health (NIH) launched the Microphysiological Systems Program [6], a collaboration
with the Defense Advanced Research Projects Agency (DARPA) and the U.S. Food and Drug Administration (FDA),
to develop human tissue chips containing bio-engineered tissue models that mimic human physiology. The aim of this
program is to use these chips to predict the safety and efficacy of candidate drugs. Within this program, our lab de-
ar
X
iv
:1
90
5.
02
12
1v
1 
 [q
-b
io.
QM
]  6
 M
ay
 20
19
Machine learning to predict developmental neurotoxicity with high-throughput data from 2D bio-engineered tissues
veloped 3D constructs of developing human neural tissue from several cell types and trained machine learning models
to predict developmental neurotoxicity with gene expression data gathered from these constructs [9]. The 3D model
is capable of accurately identifying compounds that are neurotoxic, and it shows potential for recapitulating relevant
biological mechanisms, thus demonstrating potential for further insight. Nevertheless, this 3D model is necessarily
complex and requires extensive expertise and manual effort to construct and employ successfully. In cases where the
goal is only to construct an assay of developmental neurotoxicity, we propose that it may be sufficient to use a simpler
2D tissue model cultured from a single cell type.
Here, we report results applying off-the-shelf machine learning algorithms to a simpler 2D model of neural tissue.
We run several experiments with varying numbers of chemical exposure lengths and feature selection methods. We
compare the accuracy of learned models between those trained on data from a 2D tissue model and those trained on
data from the 3D tissue model. Importantly, we find that our accuracy in distinguishing known human developmental
neurotoxins from non-toxins is substantially higher when using the 2D model than when using the 3D model. We
describe our data collection and predictive experiments in the next section, follow with a discussion of results, and
finish with conclusions and proposals for future work.
Materials and Methods
For all of our experiments, we consider a dataset of 45 compounds. Our outcome of interest is a binary prediction of
toxic or non-toxic, and of these 45 compounds, 29 are considered toxic and 16 are considered non-toxic (see Table
1). These 45 compounds are a subset of the 70 used in prior work [9]. For our experiments here, we use the same
compound concentrations and the same toxic/non-toxic binary labels assigned to each compound from this prior work.
We collect transcriptome-wide gene expression profiles via RNA sequencing (RNA-Seq) from 2D tissue cultures
following exposure to these compounds. We use the 45 compound subset of data from the prior 3D work [9] as our
comparison gene expression data from 3D tissue cultures. Throughout the paper, we refer to these datasets as the 2D
and 3D dataset, respectively. Both datasets consist of gene expression measurements in transcripts per million reads
(TPM) from 19,084 protein-coding genes for every sample. Each sample thus represents gene expression from either
a 2D or 3D tissue sample, a single compound, and a single length of exposure to that compound.
To collect gene expression data for our 2D experiments, we seeded neural progenitor cells (NPC) on Matrigel coated
plates and started compound treatment on the same day (day 0). We collected samples at 11 time points of exposure:
1, 2, 3, 4, 6, 8, 10, 15, 21, 27, and 39 days. We then performed RNA-Seq and calculated gene expression values in
transcripts per million reads. The dataset contains at most one biological sample for each compound and exposure
length. There are missing samples for some exposure lengths of some compounds because of cell death and other
experimental factors (see Table 2).
The 3D dataset contains samples at two time points of exposure: 2 and 7 days. There are two biological samples for
each compound at each time point, with no missing samples.
Overall, the goal of our prediction experiments is then to learn a model that can map from gene expression profiles
to a binary label of toxic or non-toxic. We make no a priori assumptions about the common or unique biological
effects of the compounds in the expression data. Thus, we make no attempt to separate or explicitly model different
types of toxicity or non-toxicity that each individual compound may elicit. Similarly, we make no attempt to explicitly
model the effects of different compound exposure lengths. Instead, we simply allow the machine learning algorithms
to observe samples from many different compounds at different exposure lengths and find patterns across the gene
expression profiles that are associated with toxicity or non-toxicity. Using this approach, we aim to develop an accurate
predictive model that generalizes beyond any single exposure length or type of toxicity. The primary advantage of this
approach is thus its generalizability, but the disadvantage is that analyzing the model to understand any one particular
toxic effect becomes more difficult because all individual signals are effectively combined into one broad signal.
We first give more detailed descriptions of our cell culture approach and our sequencing pipeline in the next two
subsections. We then describe and perform three sets of prediction experiments, performing each separately on the
2D and 3D datasets, and compare results. The first experiment evaluates the ability to predict toxicity by training
and testing common machine learning models on samples from a single time point of compound exposure. Next,
we evaluate the ability to predict toxicity by training and testing models using all available time points of compound
exposure pooled together. Finally, we evaluate the same models once more using all time points of exposure but with
the addition of feature selection.
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Table 1: Compounds and concentrations.
Chemical Concentration
To
xi
c
Accutane or Isotretinoin 0.5µg/ml
Amiodarone 1µg/ml
Arsenic 5µM
Benzene 50µg/ml
Bioallethrin 10nM
Bis-I 4µM
Busulfan 50µg/ml
Cadmium 50µM
Carbamazepine 10µg/ml
Cytosine β-D-arabinofuranoside 5µM
Dexamethasone 100µM
Diazinon 10µM
Dioxin 3nM
5-Fluorouracil 10µM
Hydroxyurea 250µM
2-Imidazolidinethione 0.4mM
K252a 30nM
Lead acetate 30µM
Maneb 60µM
Monosodium glutamate 150µM
Okadaic acid 3nM
PD166866 2.5µM
Permethrin 2.5µM
L-phenylalanine 1mM
Propylthiouracil 25µg/ml
(trans) Retinoic acid 1.7µM
Thalidomide 100ng/ml
U0126 10µM
Vincristine 1nM
N
on
-T
ox
ic
Acetaminophen 10µg/ml
Amoxicillin 5µg/ml
Aspirin 20µg/ml
DMSO 0.1%
Ficoll 400 10µM
Fructose 10µM
Glucosamine 0.4µg/ml
Glycerol 10µM
Glyphosate 10µM
Ibuprofen 20µg/ml
Naproxen sodium 30µg/ml
PEG 3350 10µM
PVP 100µg/ml
Saccharin 10µM
Sorbitol 10µM
Sucrose 10µM
Cell culture and neural differentiation
For our 2D tissue model, we maintained human H1 embryonic stem (ES) cells in E8 medium [10] on Matrigel (BD
Biosciences) coated plates and passaged every 4-5 days with EDTA [11]. To derive neural progenitor cells (NPC), we
split H1 cells using EDTA and immediately treated them with E7 medium (E8 medium without TGFβ-1) +SB431542
(Sigma) (10µM). After another seven days, we mechanically dissociated the formed rosettes from the culture dish and
cultured the floating aggregates in E5 medium (E8 medium without FGF2, TGFβ-1, or insulin) +N2+B27+hFGF2
(4ng/ml). Four days later, we dissociated the aggregates with Accutase (Life Technologies Inc.) and plated them onto
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Table 2: Missing samples from the 2D tissue culture dataset.
Chemical Missing Days
To
xi
c
Arsenic 8 - 39
Busulfan 8 - 39
Cadmium 8 - 39
Cytosine β-D-arabinofuranoside 8 - 39
5-Fluorouracil 8 - 21
2-Imidazolidinethione 21
Maneb 2 - 39
Okadaic Acid 8 - 39
PD166866 8
U0126 21
Vincristine 8 - 39
N
on
-T
ox
ic
Acetaminophen 8, 15
Aspirin 8 - 39
Glucosamine 15 - 39
Glycerol 8 - 27
Ibuprofen 15
Naproxen sodium 6
PEG 3350 15
Glyphosate 8, 15
Sorbitol 8 - 21
Saccharin 8 - 27
Matrigel coated plates in E5+N2+B27+hFGF2 (5ng/ml). We cultured the cells for an additional 22 days and passaged
when confluent. After culture, we cryopreserved the cells at 12 million cells per vial. We performed fluorescence-
activated cell sorting (FACS) analysis and found that these NPCs were greater than 90% SOX1+ and TubβIII+.
We thawed the NPCs and expanded them in E5+N2+B27+hFGF2 (5ng/ml) for five days before harvesting via Accutase
treatment. We then seeded roughly 105 cells into one well of a 48 well Matrigel coated plate in E5+N2+B27 and started
chemical treatment the same day (day 0). We collected samples at indicated time points by lysing cells directly on
plate with 150µl RLT lysis buffer (Qiagen).
RNA sequencing
After treatment with the compound, we purified total RNA from the NPCs using the RNeasy 96 Kit (Qiagen). We
prepared cDNA libraries, indexed with Illumina’s TruSeq RNA Sequencing Kit, and sequenced on Illumina’s HiSeq
2500, with 17-24 indexed samples per lane with 51 base-pair single reads. We generated FASTQ files with CASAVA
(v1.8.2) and mapped reads to the human transcriptome (RefGene v1.1.17) using Bowtie [12] (v0.12.8), allowing 2
mismatches and a maximum of 20 multiple hits. To produce gene expression values in TPM, we used RSEM [13]
(v1.2.1).
Classification experiments
We used four common machine learning algorithms in our classification experiments: support vector machines
(SVMs), logistic regression, random forests, and naive Bayes. Traditional support vector machines (SVM) are binary
classifiers that construct a maximum-margin decision boundary separating the two classes of training samples [14].
Logistic regression is a binary classification algorithm that models the posterior probability of the response variable
as a logistic function applied to a linear combination of the predictor variables and model coefficients [15]. Random
forest classifiers produce class predictions by aggregating over an ensemble of decision trees [16], each of which was
fit using a bootstrap sample of the training dataset. Naive Bayes is a probabilistic graphical model that makes the
strong simplifying assumption that all predictor variables are conditionally independent of one another given the class
label [17].
We used the Scikit-learn [18] (v0.18.2) implementations of these algorithms, specifically the SVC,
LogisticRegression, RandomForestClassifier, and MultinomialNB classes, respectively. For SVMs, we used
a linear kernel, probability estimates, and scaled gene expression values to [0.0, 1.0]. For logistic regression, we stan-
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Figure 1: AUCs for single day train and test on the 2D (top) and 3D (bottom) tissue culture datasets. Error bars around
points give a 95% confidence interval from five replicate runs of each.
dardized the data, used L2 regularization, and used the dual formulation. For both SVMs and logistic regression,
we used internal cross-validation to select the C parameter from {0.0001, 0.001, 0.01, 0.1, 1.0, 10.0, 100.0, 1000.0}.
For random forests, we used the entropy splitting criterion and 100 trees. We used the default settings for all other
algorithm parameters.
To evaluate the predictive performance of these algorithms, we used the receiver operating characteristic (ROC) curve
and the area under the curve (AUC). We used this standard metric to get an overall sense of predictive performance
without having to choose a single classification threshold for each model. An AUC of 1.0 represents a perfect ordering
of toxic and non-toxic compounds, whereas an AUC of 0.5 represents random guessing.
We used a standard leave-one-compound-out cross-validation for all of our experiments to avoid overly optimistic
estimates of future predictive performance. This means that we performed each experiment in 45 steps, corresponding
with the 45 compounds in our dataset. For each step, a single compound was held out of the training set, a model was
trained on the remaining 44 compounds, and the model was used to make a prediction for the held out compound.
We then aggregated the predictions across all 45 compounds to make the final ROC curve evaluation. Note that in
experiments where we pooled multiple samples for each compound (e.g. samples from different time points), we held
out all samples for the held out compound at once and averaged the predicted probabilities across samples to produce
the final compound prediction.
For our first classification experiment, we trained and tested our models using only one compound exposure length at
a time. The experiment shows there is variation in predictive performance over the extent of exposure lengths. We
5
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Figure 2: Comparison of AUCs between 2D and 3D tissue culture methods when all available exposure lengths are
pooled for train and test (top), and when only two days of exposure are pooled for the 2D method (bottom). The 3D
results are the same in both. Error bars around points give a 95% confidence interval from five replicate runs of each
experiment.
ran five replicates of each to account for AUC variations between runs due to randomness in some of the algorithms.
Results for the 2D and 3D datasets can be found in Figure 1.
For our second classification experiment, we trained and tested our models by pooling samples from all exposure
lengths together into one dataset. Recall that we do not explicitly model the different exposure lengths, instead opting
to simply include different exposure lengths as additional samples of the same compounds. Again, we computed prob-
ability estimates for each compound by averaging the individual sample estimates. As before, we ran five replicates
of each. Figure 2 (top) shows a comparison of AUCs for each of the algorithms between the 2D and 3D tissue culture
methods.
Because there are fewer exposure lengths in the 3D dataset, there is a chance that differences in accuracy between the
2D and 3D dataset are a result of having many more exposure lengths in the 2D dataset. To account for this difference,
we ran two smaller pooled experiments in the 2D dataset combining only two exposure lengths each. The exposure
lengths in the 3D dataset are two days and seven days, but we do not have a seven day exposure length in our 2D
dataset. Six and eight days of exposure are the closest analogous lengths in the 2D dataset. Thus, we ran these two
day experiments in two ways, once by pooling days two and six, and another by pooling days two and eight. Again,
we ran five replicates of each. Figure 2 (bottom) shows the results.
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Feature selection experiments
We next trained the same models using all days pooled, but also applied feature selection. We ran experiments on 19
different fixed sizes of selected gene sets: 1,000 genes down through 100 with a step size of 100, and through 10 genes
with a step size of 10. We chose these gene set sizes to demonstrate a wide range of model performance from large
triple digit feature sets all the way down to small double digit sets. We used the same feature selection algorithms
for the 2D and 3D datasets, and all algorithms used the same set of selected features for their respective datasets. We
performed feature selection for each fold of cross-validation with the same data used for training the predictive models
to avoid overly optimistic estimates of AUC.
We used three algorithms for our feature selection experiments: recursive feature elimination, filtering by mutual
information, and sparse logistic regression. Recursive feature elimination works by recursively training a linear model
and eliminating the least important features in each step, until some stopping condition is met [19] (e.g. a desired
feature set size). Mutual information feature selection ranks all features by their mutual information with the class
label and then filters to a specified feature set size [20]. Sparse logistic regression works by applying L1, rather than
L2, regularization to the model, driving many feature coefficients to 0 and thus leading to a smaller feature set [21].
Again, we used Scikit-learn [18] implementations for these algorithms, specifically the RFE, SelectKBest, and
LogisticRegression classes, respectively. For recursive feature elimination, we scaled expression values to [0.0,
1.0], used a linear SVM with C set to 1.0, and used a step size of 1%. For sparse logistic regression selection, we
standardized the data, used L1 regularization, and set C to 1.0. We used the default settings for all other parameters.
Note that the RFE and mutual information methods easily lend themselves to selection of exact numbers of genes,
whereas spare logistic regression does not. Thus, for sparse logistic regression, we first ran the sparse model and
then selected the top K genes by the magnitude of their learned coefficients. We skipped experiments with the sparse
logistic regression method when K was larger than the number of non-zero learned coefficients. As before, we ran
five replicates of each experiment to account for AUC variations between runs. Figures 3 and 4 show the results from
these experiments on the 2D and 3D datasets, respectively.
Because we performed feature selection for each fold of leave-one-compound-out cross-validation, each feature se-
lection method was essentially performed 45 times for each gene set size. To assess the variability of each feature
selection method on these datasets, we report the number of unique genes selected across all folds combined for each
method at a gene set size of 10 (see Table 3). Each feature selection method may thus pick a maximum of 450 genes,
and a minimum of 10, across all folds.
Table 3: Cross-validation unions of selected genes with K of 10.
Culture RFE Mutual Info Sparse LR
2D 99 25 37
3D 153 81 41
Results and Discussion
Figure 1 shows the single day-by-day prediction results for the 2D and 3D datasets. Each point along the x-axis shows
the predictive performance of a model that is trained and tested on samples at a single length of compound exposure
in days. Error bars around the points show a 95% confidence interval from the five replicate runs of each algorithm
and exposure length. Recall that 1.0 is a perfect AUC, while 0.5 is equivalent to random guessing. One commonality
between the two culture methods is that naive Bayes does not appear to perform as well as the other three algorithms.
This is perhaps unsurprising due to the high dimensionality of the dataset, which skews naive Bayes’ predictions
more toward 0.0 and 1.0. Predictive performance appears to improve overall at longer exposure lengths in the 2D
dataset. This same trend is not immediately apparent in the 3D dataset, but trends are difficult to support with only
two exposure lengths. The overall result, however, indicates that we can exceed the predictive performance of the 3D
tissue model using the simpler 2D tissue model.
Figure 2 (top) shows a side-by-side comparison of the models on the 2D and 3D datasets when all available exposure
lengths are pooled for training and testing. Again, error bars around the points show a 95% confidence interval from
the five replicate runs of each. All of the models have substantially better AUC on the 2D dataset than on the 3D
dataset. Naive Bayes again does not appear to perform as well as the other algorithms, but has substantially better
accuracy on the 2D dataset once all of the samples are pooled.
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Figure 3: AUCs for models trained and tested with feature selection on all exposure lengths pooled for the 2D dataset.
The horizontal axis is the selected gene set size. Error bars give a 95% confidence interval from five replicate runs.
Recall that the 2D dataset has several more compound exposure lengths than the 3D dataset. Figure 2 (bottom) shows
results on the 2D dataset when pooling only two days of compound exposure, which is analogous to the two available
in the 3D dataset. Again, naive Bayes does not perform as well as the other algorithms. Still, in all cases, the 2D models
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Figure 4: AUCs for models trained and tested with feature selection on all exposure lengths pooled for the 3D dataset.
The horizontal axis is the selected gene set size. Error bars give a 95% confidence interval from five replicate runs.
perform better than the analogous experiments on the 3D dataset. This suggests that the accuracy of the models on the
2D dataset is not simply a result of having a greater number of samples from a larger range of compound exposure
lengths.
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Finally, Figures 3 and 4 show results from the same pooled models with the addition of three feature selection methods.
The horizontal axis gives the AUC at 19 decreasing gene set sizes, from 1,000 genes down to 10 genes. The results
show a common trend of accuracy degradation with smaller gene set sizes, but the trend is more pronounced in the 3D
dataset. For example, no method has an AUC above 0.8 in the 3D dataset at a gene set size of 10, whereas all but one
method has an AUC above 0.9 in the 2D dataset.
In addition to better prediction, Table 3 shows that all of the feature selection methods generally selected more con-
sistent sets of genes across folds on the 2D dataset, suggesting that the predictive signal may be less distributed in the
2D dataset than in the 3D dataset. Note that there is no overlap between the 2D and 3D selected gene sets for any of
the three methods, suggesting that the predictive signal is also distinct between 2D and 3D.
Overall, the 2D tissue model appears to produce more accurate and more consistent predictive models. Two obvious
potential explanations for this stand out. First, the 2D tissue model, being composed of only one cell type, is less
complex than the 3D model and thus produces a less variable signal. Second, compound diffusion is likely more
complete in the 2D tissue model than in 3D. Both of these potential explanations could lead to stronger signals of gene
expression perturbation for the machine learning algorithms to detect.
Conclusions
Here, we present common machine learning models applied to the task of predicting developmental neurotoxicity of
several compounds from gene expression data. We compare the AUCs of these models between datasets collected
from a 2D tissue culture approach, and a more complex 3D tissue culture approach. We compare results from training
models on single lengths of compound exposure, from multiple pooled lengths of exposure, and with the addition of
feature selection. Overall, our results show that the models trained on data collected from a simpler 2D tissue model
are more accurate than those trained on data from a 3D model. While a 3D tissue model is perhaps more likely to
recapitulate relevant biology needed to fully understand toxicity mechanisms, a 2D tissue model is certainly a viable
option and easier to produce efficiently [22]. We would thus still recommend a 3D tissue model if the primary goal is
to study biological mechanisms in depth, but our results here suggest that the 2D tissue model is an excellent choice
for producing a broad toxicity assay.
Furthermore, our results show that models trained on the 2D data experience very little degradation in AUC under
stringent feature selection, whereas the models trained on 3D data show extensive degradation. Our results also
demonstrate that the genes selected were more consistent across folds on the 2D data than on the 3D data; this is
important because it suggests that we may be able to simplify the model even further by reducing the number of genes
that need to be quantified to perhaps far fewer than 100 without loss of accuracy. With a much smaller gene set, it may
be possible to develop a similar assay using quantification methods that are still faster and cheaper than RNA-Seq. We
propose this direction of research for future work.
We further propose evaluating the use of 2D tissue models made from simpler cell types than NPCs to predict devel-
opmental neurotoxicity or toxicity in general. NPCs require substantial experience to successfully differentiate and
culture, whereas a tissue culture based on a cell type such as dermal fibroblasts may be more approachable. While
such a cell type may not be neural in nature, and the pattern of response would surely be different, the cell may still
exhibit gene expression perturbations indicative of toxicity sufficient for the purposes of an assay.
Current models for toxicity screening are simply too slow and expensive to comprehensively test all new or less
understood chemical exposures. These models are certainly here to stay for the foreseeable future, but high-throughput
screening methods, such as we have presented here, show a great deal of potential. We hope and expect that both
of these approaches may complement one another and accelerate findings by helping stakeholders choose which
exposures to explore further and with what urgency.
Data Availability
Our 2D tissue model is available through GEO Series accession number GSE126786, and the 3D tissue model data we
use for comparison is available through GEO Series accession number GSE63935. All code and processed expression
data can be found on Github at https://github.com/finnkuusisto/DevTox2D.
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